Article Details
Retrieved on: 2021-06-24 17:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... co-develop and co-commercialize domvanalimab, an anti-TIGIT candidate and Fc-silent investigational monoclonal antibody. As Arcus continues to ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here